查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1370971

病毒檢測試劑盒市場 - 2018-2028 年全球產業規模、佔有率、趨勢、機會和預測，按測試類型、按應用、最終用戶、地區和競爭細分

Virus Testing Kits Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Test Type, By Application, By End User, By Region and Competition
出版日期: | 出版商: TechSci Research | 英文 190 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2022年，全球病毒檢測試劑盒市場估值達到148.4億美元，預計在預測期內大幅成長，預計年複合成長率（CAGR）為5.55%，到2028年預計將達到204.3億美元。檢測試劑盒是重要的診斷工具，用於透過各種檢測方法（包括DFA、凝集檢測、PCR 和固相檢測）檢測感染者體內的抗體。病毒逐漸影響淋巴球，而淋巴球在人體的免疫防禦中扮演至關重要的角色。先進的技術平台，例如用於核酸視覺識別的酶輔助奈米複合物，可以設計用於檢測多種疾病。這些試劑盒有助於控制新興傳染病和高流行感染。它們是基於病毒學實驗室常用的快速抗原檢測、血清學和分子診斷技術來檢測病毒抗體。

主要市場促進因素

1. 傳染病日益流行

市場概況
預測期 2024-2028
2022 年市場規模 148.4億美元
2028 年市場規模 204.3億美元
2023-2028 年CAGR 5.55%
成長最快的細分市場 肝炎
最大的市場 北美洲

全球罕見疾病負擔日益增加，需要對各種慢性病進行準確的診斷和有效的治療策略。由於對末期疾病症狀的認知提高，中國、印度、日本、巴西和其他東南亞國家等發展中國家的診斷率有所提高。然而，即使擁有技術先進的診斷設備，微小的人為錯誤仍然會阻礙這一過程，導致大量患者在早期階段未被診斷出來，並使治療變得複雜。流感流行和大流行對個人和人群都有深遠的影響。流感的負擔因年齡和基本健康狀況而異，高風險患者，如老年人和已有疾病的患者，會更頻繁地住院和護理。隨著患者人數持續成長，評估流感負擔的需求日益增加，特別是由於醫療費用不斷上漲。然而，要準確估計疾病盛行率可能具有挑戰性，因為流感經常被誤認為是其他病毒性疾病，導致漏報。除了與醫療相關的直接成本（例如缺勤和工作效率損失）之外，流感的間接成本也相當可觀。法國、美國和德國的成本估算表明，間接成本可能比直接成本高出五到十倍。因此，了解流感的真正負擔對於有效的資源分配和緩解策略至關重要。

2. 早期診斷意識的提高

人們對早期診斷的認知不斷提高，在增加病毒檢測試劑盒的需求方面發揮重要作用。早期診斷對於有效的疾病管理、疫情控制和公共衛生干預至關重要。隨著人們對及時檢測重要性的認知不斷增強，對病毒檢測試劑盒的需求預計將會增加。早期診斷可以及時進行醫療干預，從而獲得更好的治療結果，並有可能預防疾病進展或併發症。對於傳染病，例如病毒爆發，早期診斷有助於及時識別和隔離感染者，減少病毒在社區內的傳播。快速檢測和早期診斷使感染者能夠採取適當的預防措施，防止將病毒傳播給其他人，從而為整體公共衛生工作做出貢獻。早期診斷有助於識別和通知感染者的密切接觸者，促進有效的接觸者追蹤和遏制策略。及時診斷使醫療保健系統能夠有效地分配資源，包括病床、醫療用品和醫護人員。

3. 快速檢測疾病的需求不斷成長

對疾病快速檢測的需求不斷成長是推動病毒檢測試劑盒需求增加的關鍵因素。快速、準確的疾病檢測對於及時介入、有效治療和公共衛生遏制工作至關重要。快速檢測可以及早開始適當的治療，從而改善患者的治療結果，並有可能預防疾病進展或併發症。對於傳染病，快速檢測有助於快速識別和隔離感染者，最大限度地減少疾病在社區內傳播的可能性，並減少疫情爆發的整體影響。快速檢測能夠及時追蹤接觸者並通知與感染者有過密切接觸的人，有助於防止進一步傳播。快速檢測在醫療機構等高風險環境中至關重要，快速識別感染可以防止疾病在患者和醫護人員之間傳播。公共衛生意識、全球旅行、新出現的疾病和技術進步等因素的融合使人們越來越認知到快速檢測疾病的必要性。這種認知反過來又推動了對病毒檢測試劑盒的需求增加，這些試劑盒可以提供快速、準確的結果，從而能夠及時應對各種疾病威脅。

4. 新型病毒檢測試劑盒介紹

新型病毒檢測試劑盒的推出是病毒檢測試劑盒需求增加的重要動力。這些新穎的試劑盒通常帶來技術、便利性、準確性、速度和可及性方面的進步，從而提高了人們對各種傳染病檢測的興趣。新型檢測試劑盒通常利用創新技術來提高病毒檢測的敏感度和特異性，減少假陰性或假陽性的可能性。與可能需要更長時間的傳統測試方法相比，許多新的測試套件可以快速提供結果，有時只需幾分鐘或幾小時。這種速度對於及時診斷和疾病管理至關重要。一些新穎的檢測套件專為即時護理使用而設計，使得檢測能夠在傳統醫療環境之外進行。這種可訪問性擴大了測試範圍和便利性。新穎的檢測套件通常旨在易於使用，使其適合更廣泛的醫療保健專業人員和環境。這可能會導致測試採用率的提高。家庭測試套件的推出使個人能夠在舒適的家中進行自我測試，從而提高了測試的可用性和隱私性。新型病毒檢測試劑盒的推出滿足了對準確、方便和快速檢測解決方案日益成長的需求。隨著技術的不斷發展和醫療保健需求的發展，這些進步有助於更廣泛地採用檢測實踐並更加重視疾病檢測和遏制。

主要市場挑戰

1. LMIC（低收入和中等收入國家）經濟體缺乏認知

由於病毒診斷產品的生命週期較短以及法規核准方法的變化，診斷領域與製藥業的其他領域有所不同。在政府改善醫療設施和不斷增加的患者人數的推動下，診斷市場正在經歷成長，特別是在新興國家。然而，與已開發經濟體相比，新興經濟體獲得診斷測試的機會有限仍然是一個挑戰。由於識字率低、缺乏網路連線和醫療基礎設施有限等挑戰，中低收入國家經濟體獲得可靠資訊的機會往往有限。這導致人們對病毒檢測的重要性和檢測試劑盒的可用性缺乏認知。許多中低收入國家在向其人民提供充分的健康教育方面面臨挑戰。因此，個人可能無法完全理解及時檢測傳染病的重要性。

2. 複雜的監管環境阻礙市場成長

嚴格而複雜的監管要求可能會導致新病毒檢測試劑盒批准的延遲。這可能會減慢創新和改進的測試技術推向市場的速度。滿足複雜的監管標準通常需要在研究、測試、文件和品質保證流程方面進行大量投資。這會增加測試套件的開發和製造成本。由於克服監管障礙帶來的挑戰，複雜的法規可能會阻礙製造商投資研發。不同的國家或地區可能有不同的監管要求，這給想要在國際上分銷其檢測套件的製造商帶來了挑戰。這可能會阻礙市場擴張。較小的製造商或新創公司可能會發現很難通過複雜的監管流程，從而為進入市場設置障礙。這會限制競爭和創新。不同類型的病毒檢測試劑盒（例如診斷、篩檢、監測）可能面臨不同的監管途徑，為提供多種產品的製造商帶來複雜性。

主要市場趨勢

1. 新興經濟體提供豐厚的成長機會

印度、巴西和中國等新興經濟體為私人醫療部門提供了利潤豐厚的機會。跨國公司透過合作或收購當地診斷公司在這些國家建立了自己的業務。在印度、中國和巴西等發展中國家，生活水準的提高和人口老化推動了對慢性病診斷和管理的需求，疾病負擔正在轉變。新興經濟體為私營衛生部門提供了巨大的成長潛力。中產階級的崛起、城市化進程的加速以及可支配收入的成長正在推動對品質醫療服務的更高需求，包括慢性病的診斷、治療和管理。許多跨國醫療保健公司認知到這些市場的機遇，並透過策略夥伴關係、合作、收購或投資當地診斷公司來建立自己的影響力。這使他們能夠利用當地的專業知識和基礎設施，同時擴大其全球足跡。與當地診斷公司合作或收購當地診斷公司可以讓跨國公司了解當地市場動態、監管框架和患者需求。這使他們能夠有效地客製化產品並應對監管挑戰。這些因素共同為病毒診斷試劑盒製造商帶來了光明的成長前景。

2. 移動測試裝置

配備檢測設施的行動檢測單元可以到達偏遠和服務不足的地區，提高檢測的可及性和覆蓋範圍。移動偵測裝置可以克服地理障礙，到達遠離醫療機構的地區。這確保了生活在偏遠地區的個人無需長途跋涉即可獲得檢測服務。缺乏交通基礎設施可能是獲得醫療服務的主要障礙。行動裝置消除了個人出行的需要，使測試變得更加方便和容易。移動檢測單位可以專門針對服務不足的社區，這些社區可能缺乏適當的醫療設施。這種方法有助於縮小醫療保健差距，並確保每個人都有機會接受檢測。

細分市場洞察

測試類型見解

根據測試類型，市場分為 DFA 測試、側流測試、RT-PCR、凝集測定、固相測定等。 DFA 測試由於使用螢光標記抗體來檢測特定病毒抗原的存在而佔據了市場主導地位。它們已用於診斷某些病毒，例如流感等呼吸道病毒和呼吸道合胞病毒（RSV），這些病毒在人群中普遍流行。此外，RT-PCR 是市場上快速成長的領域，因為透過聚合酶鍊式反應 (PCR) 檢測廣泛使用核酸檢測。寡核苷酸合成、核酸萃取標準化自動化程序以及 PCR 產物即時檢測的進步進一步支持了這一點，預計未來幾年將增加對 RT-PCR 的需求。

最終使用者見解

根據最終用戶，市場分為醫院和診所、診斷中心和實驗室、學術和研究機構等。醫院和診所是個人尋求醫療協助的主要醫療機構。這些設置執行各種類型的病毒測試來診斷感染並指導患者治療，這就是為什麼醫院和診所部門預計將在預測期內主導市場的原因。

區域洞察

在試劑盒製造公司對研發的大量投資以及眾多檢測實驗室和醫院的建立的推動下，北美是病毒檢測診斷試劑盒市場的主導力量。該地區對病毒檢測診斷試劑盒的需求不斷成長，特別是由於寨卡病毒感染的流行，推動了整個預測期內市場的成長。此外，創新檢測試劑盒的推出以及有關產品製造的有利政府法規預計將為北美病毒診斷檢測試劑盒市場提供強勁的成長平台。

目錄

第 1 章：產品概述

  • 市場定義
  • 市場範圍
    • 涵蓋的市場
    • 研究年份
    • 主要市場區隔

第 2 章：研究方法

  • 研究目的
  • 基線方法
  • 主要產業夥伴
  • 主要協會和二手資料來源
  • 預測方法
  • 數據三角測量與驗證
  • 假設和限制

第 3 章：執行摘要

  • 市場概況
  • 主要市場細分概述
  • 主要市場參與者概述
  • 重點地區/國家概況
  • 市場促進因素、挑戰、趨勢概述

第 4 章：客戶之聲

第 5 章：全球病毒檢測試劑盒市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依測試類型（DFA 測試、側流層析測試、RT-PCR、凝集測定、固相測定等）
    • 按應用（流感、肝炎、愛滋病毒、麻疹/風疹、輪狀病毒、其他）
    • 按最終使用者（醫院和診所、診斷中心和實驗室、學術和研究機構、其他）
    • 按地區
    • 按公司分類 (2022)
  • 市場地圖

第 6 章：北美病毒檢測試劑盒市場前景

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按測試類型
    • 按應用
    • 按最終用戶
    • 按國家/地區
  • 北美：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第 7 章：歐洲病毒檢測試劑盒市場前景

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按測試類型
    • 按應用
    • 按最終用戶
    • 按國家/地區
  • 歐洲：國家分析
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙

第 8 章：亞太地區病毒檢測試劑盒市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按測試類型
    • 按應用
    • 按最終用戶
    • 按國家/地區
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第 9 章：南美洲病毒檢測試劑盒市場前景

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按測試類型
    • 按應用
    • 按最終用戶
    • 按國家/地區
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第 10 章：中東和非洲病毒檢測試劑盒市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按測試類型
    • 按應用
    • 按最終用戶
    • 按國家/地區
  • MEA：國家分析
    • 南非病毒檢測套件
    • 沙烏地阿拉伯病毒檢測試劑盒
    • 阿拉伯聯合大公國病毒檢測試劑盒

第 11 章：市場動態

  • 促進要素
  • 挑戰

第 12 章：市場趨勢與發展

  • 近期發展
  • 併購
  • 產品發布

第 13 章：全球病毒檢測試劑盒市場：SWOT 分析

第 14 章：波特的五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 客戶的力量
  • 替代產品的威脅

第15章：競爭格局

  • 商業概覽
  • 服務內容
  • 最近的發展
  • 主要人員
  • SWOT分析
    • Qiagen
    • Abbott
    • Thermo Fisher Scientific
    • Becton, Dickinson and Company
    • BioMerieux SA
    • Quidel Corporation
    • .Rapikit
    • Zoetis Inc
    • Luminex Corporation
    • F. Hoffmann-La Roche Ltd

第 16 章：策略建議

第 17 章：關於我們與免責聲明

簡介目錄
Product Code: 4596

The Global Virus Testing Kits Market reached a valuation of USD 14.84 Billion in 2022 and is poised for substantial growth in the forecast period, with a projected Compound Annual Growth Rate (CAGR) of 5.55% and expected to reach USD 20.43 Billion through 2028. Virus testing kits serve as vital diagnostic tools used to detect antibodies in infected individuals through various testing methods, including DFA, agglutinating testing, PCR, and solid-stage testing. Viruses progressively affect lymphocytes, which play a crucial role in the body's immune defense. Advanced technology platforms, such as enzyme-assisted nano complexes for visual identification of nucleic acids, can be designed to detect a wide range of diseases. These kits are instrumental in controlling emerging infectious diseases and high-prevalence infections. They are based on techniques commonly employed in virology laboratories for rapid antigen testing, serology, and molecular diagnostics to detect virus antibodies.

Key Market Drivers

1. Growing Prevalence of Infectious Diseases

Market Overview
Forecast Period2024-2028
Market Size 2022USD 14.84 Billion
Market Size 2028USD 20.43 Billion
CAGR 2023-20285.55%
Fastest Growing SegmentHepatitis
Largest MarketNorth America

The increasing global burden of rare diseases necessitates accurate diagnosis and effective treatment strategies for various chronic conditions. Developing countries such as China, India, Japan, Brazil, and other Southeast Asian nations have witnessed improved diagnosis rates due to heightened awareness of terminal illness symptoms. However, even with technologically advanced diagnostic equipment, a small margin of human error still hinders the process, resulting in a significant number of patients remaining undiagnosed at an early stage and complicating treatment. Influenza epidemics and pandemics have a profound impact on both individuals and populations. The burden of influenza varies depending on age and underlying health conditions, with high-risk patients, such as the elderly and those with pre-existing medical conditions, experiencing more frequent hospitalizations and care. As patient populations continue to grow, there is an increasing need to assess the burden of influenza, particularly due to escalating medical costs. However, accurately estimating disease prevalence can be challenging, as influenza is often mistaken for other viral illnesses, leading to under-reporting. In addition to direct costs associated with medical care, such as absenteeism and loss of work efficiency, indirect costs of influenza are substantial. Cost estimates from France, the United States, and Germany have shown that indirect costs can be five to ten times higher than direct costs. Thus, understanding the true burden of influenza is crucial for effective resource allocation and mitigation strategies.

2. Rising Awareness Regarding Early Diagnosis

Rising awareness regarding early diagnosis plays a significant role in increasing the demand for virus testing kits. Early diagnosis is crucial for effective disease management, outbreak control, and public health interventions. As awareness about the importance of timely testing grows, the demand for virus testing kits is expected to rise. Early diagnosis allows for timely medical intervention, which can lead to better treatment outcomes and potentially prevent disease progression or complications. In the case of infectious diseases, such as viral outbreaks, early diagnosis helps identify and isolate infected individuals promptly, reducing the spread of the virus within communities. Rapid testing and early diagnosis enable infected individuals to take appropriate precautions to prevent transmitting the virus to others, contributing to overall public health efforts. Early diagnosis aids in identifying and notifying close contacts of infected individuals, facilitating effective contact tracing and containment strategies. Timely diagnosis allows healthcare systems to allocate resources efficiently, including hospital beds, medical supplies, and healthcare personnel.

3. Growing Need for Rapid Detection of Diseases

The growing need for rapid detection of diseases is a key factor driving the increased demand for virus testing kits. Rapid and accurate disease detection is crucial for timely intervention, effective treatment, and public health containment efforts. Rapid detection allows for early initiation of appropriate medical treatment, which can lead to improved patient outcomes and potentially prevent disease progression or complications. For infectious diseases, rapid detection helps identify and isolate infected individuals quickly, minimizing the potential spread of the disease within communities and reducing the overall impact of an outbreak. Rapid detection enables prompt contact tracing and notification of individuals who have been in close contact with infected individuals, helping to prevent further transmission. Rapid testing is crucial in high-risk environments such as healthcare settings, where quick identification of infections can prevent the spread of diseases among patients and healthcare workers. The convergence of factors such as public health awareness, global travel, emerging diseases, and technological advancements has led to a growing recognition of the need for rapid disease detection. This recognition, in turn, is driving increased demand for virus testing kits that offer quick and accurate results, enabling timely responses to various disease threats.

4. Introduction of Novel Viral Testing Kits

The introduction of novel viral testing kits is a significant driver of increased demand for virus testing kits. These novel kits often bring advancements in technology, convenience, accuracy, speed, and accessibility, leading to a heightened interest in testing for various infectious diseases. Novel testing kits often utilize innovative technologies that enhance the sensitivity and specificity of virus detection, reducing the likelihood of false negatives or false positives. Many new testing kits offer rapid results, sometimes within minutes or hours, compared to traditional testing methods that might take longer. This speed is crucial for timely diagnosis and disease management. Some novel testing kits are designed for point-of-care use, enabling testing to be conducted outside of traditional healthcare settings. This accessibility expands testing reach and convenience. Novel testing kits are often designed for ease of use, making them suitable for a broader range of healthcare professionals and settings. This can lead to increased testing adoption. The introduction of home testing kits empowers individuals to test themselves in the comfort of their homes, increasing testing availability and privacy. The introduction of novel viral testing kits aligns with the increasing demand for accurate, accessible, and rapid testing solutions. As technology continues to evolve and healthcare needs evolve, these advancements contribute to a broader adoption of testing practices and a heightened emphasis on disease detection and containment.

Key Market Challenges

1. Lack of Awareness Across LMIC (Low- and Middle-Income Countries) Economies

The field of diagnosis distinguishes itself from other sectors of the pharmaceutical industry due to a shorter life cycle for virus diagnostic products and variations in regulatory approval methods. The diagnostic market is experiencing growth, particularly in emerging countries, driven by government initiatives to improve healthcare facilities and an increasing patient population. However, limited accessibility to diagnostic tests in emerging economies remains a challenge compared to developed economies. LMIC economies often have limited access to reliable information due to challenges such as low literacy rates, lack of internet connectivity, and limited healthcare infrastructure. This results in a lack of awareness about the importance of virus testing and the availability of testing kits. Many LMICs face challenges in providing adequate health education to their populations. As a result, individuals may not fully understand the importance of timely testing for infectious diseases.

2. Complex Regulatory Scenarios to Impede Market Growth

Stringent and complex regulatory requirements can lead to delays in obtaining approvals for new virus testing kits. This can slow down the introduction of innovative and improved testing technologies to the market. Meeting complex regulatory standards often requires significant investments in research, testing, documentation, and quality assurance processes. This can increase the cost of development and manufacturing for testing kits. Complex regulations may discourage manufacturers from investing in research and development due to the challenges associated with navigating regulatory hurdles. Different countries or regions may have varying regulatory requirements, creating challenges for manufacturers aiming to distribute their testing kits internationally. This can hinder market expansion. Smaller manufacturers or startups might find it difficult to navigate complex regulatory processes, creating barriers to entering the market. This can limit competition and innovation. Different types of virus testing kits (e.g., diagnostic, screening, surveillance) might face different regulatory pathways, creating complexity for manufacturers offering multiple products.

Key Market Trends

1. Emerging Economies to Offer Lucrative Growth Opportunities

Emerging economies like India, Brazil, and China present lucrative opportunities for the private health sector. Multinational companies have established their presence in these countries through partnerships or acquisitions of local diagnostic firms. In developing nations such as India, China, and Brazil, where improving living standards and an aging population drive the demand for chronic disease diagnosis and management, the disease burden is undergoing a transformation. Emerging economies offer immense potential for growth in the private health sector. The rising middle class, increased urbanization, and growing disposable incomes are driving higher demand for quality healthcare services, including diagnostics, treatments, and management of chronic diseases. Many multinational healthcare companies recognize the opportunities in these markets and are establishing their presence through strategic partnerships, collaborations, acquisitions, or investments in local diagnostic firms. This allows them to leverage local expertise and infrastructure while expanding their global footprint. Collaborating with or acquiring local diagnostic firms provides multinational companies with an understanding of local market dynamics, regulatory frameworks, and patient needs. This enables them to tailor their offerings effectively and navigate regulatory challenges. These factors collectively contribute to the promising growth prospects for manufacturers of virus diagnostic kits.

2. Mobile Testing Units

Mobile testing units equipped with testing facilities can reach remote and underserved areas, improving testing accessibility and coverage. Mobile testing units can overcome geographical barriers by reaching areas that are far from healthcare facilities. This ensures that individuals living in remote regions have access to testing services without the need to travel long distances. Lack of transportation infrastructure can be a major obstacle to accessing healthcare services. Mobile units eliminate the need for individuals to travel, making testing more convenient and accessible. Mobile testing units can specifically target underserved communities, which may lack proper healthcare facilities. This approach helps bridge the healthcare gap and ensures that everyone has an opportunity to get tested.

Segmental Insights

Test Type Insights

Based on the test type, the market is segmented into DFA tests, lateral flow tests, RT-PCR, agglutination assays, solid-phase assays, and others. DFA tests dominated the market due to their use of fluorescently labeled antibodies to detect the presence of specific viral antigens. They have been used for diagnosing certain viruses, such as respiratory viruses like influenza and respiratory syncytial virus (RSV), which are commonly prevalent among the population. Moreover, RT-PCR is the rapidly growing segment in the market as nucleic acid detection is extensively utilized through the employment of polymerase chain reaction (PCR) assays. This is further supported by advancements in oligonucleotide synthesis, standardized automated procedures for nucleic acid extraction, and real-time detection of PCR products, which is expected to increase the demand for RT-PCR in the upcoming years.

End User Insights

Based on the end user, the market is segmented into hospitals & clinics, diagnostic centers & laboratories, academic & research institutions, and others. Hospitals and medical clinics are primary healthcare facilities where individuals seek medical attention. These settings perform various types of virus testing to diagnose infections and guide patient treatment, which is why the hospitals & clinics segment is expected to dominate the market in the forecast period.

Regional Insights

North America is a dominant force in the viral test diagnostic kits market, driven by substantial investments in research and development by kit manufacturing firms, as well as the establishment of numerous testing laboratories and hospitals. The region's growing demand for viral test diagnostic kits, particularly due to the prevalence of Zika virus infections, has contributed to its market growth throughout the forecast period. Furthermore, the introduction of innovative test kits and favorable government regulations pertaining to product manufacturing are expected to provide a robust growth platform for the viral diagnostic test kits market in North America.

Key Market Players

  • Qiagen
  • Abbott
  • Thermo Fisher Scientific
  • Becton, Dickinson and Company
  • BioMerieux SA
  • Quidel Corporation
  • .Rapikit
  • Zoetis Inc
  • Luminex Corporation
  • F. Hoffmann-La Roche Ltd

Report Scope:

In this report, the Global Virus Testing Kits Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Virus Testing Kits Market, By Test Type:

  • DFA Tests
  • Lateral Flow Tests
  • RT-PCR
  • Agglutination Assays
  • Solid-Phase Assays
  • Others

Virus Testing Kits Market, By Application:

  • Influenza
  • Hepatitis
  • HIV
  • Measles/Rubella
  • Rotavirus
  • Others

Virus Testing Kits Market, By End User:

  • Hospitals & Clinics
  • Diagnostic Centres & Laboratories
  • Academic & Research Institutions
  • Others

Virus Testing Kits Market, By Region:

  • North America
  • United States
  • Canada
  • Mexico
  • Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
  • Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • South America
  • Brazil
  • Argentina
  • Colombia
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait
  • Turkey
  • Egypt

Competitive Landscape

  • Company Profiles: Detailed analysis of the major companies present in the Global Virus Testing Kits Market.

Available Customizations:

  • Global Virus Testing Kits market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validations
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Virus Testing Kits Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Test Type (DFA Tests, Lateral Flow Tests, RT-PCR, Agglutination Assays, Solid-Phase Assays, Others)
    • 5.2.2. By Application (Influenza, Hepatitis, HIV, Measles/Rubella, Rotavirus, Others)
    • 5.2.3. By End User (Hospitals & Clinics, Diagnostic Centres & Laboratories, Academic & Research Institutions, Others)
    • 5.2.4. By Region
    • 5.2.5. By Company (2022)
  • 5.3. Market Map

6. North America Virus Testing Kits Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Test Type
    • 6.2.2. By Application
    • 6.2.3. By End User
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Virus Testing Kits Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Test Type
        • 6.3.1.2.2. By Application
        • 6.3.1.2.3. By End User
    • 6.3.2. Canada Virus Testing Kits Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Test Type
        • 6.3.2.2.2. By Application
        • 6.3.2.2.3. By End User
    • 6.3.3. Mexico Virus Testing Kits Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Test Type
        • 6.3.3.2.2. By Application
        • 6.3.3.2.3. By End User

7. Europe Virus Testing Kits Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Test Type
    • 7.2.2. By Application
    • 7.2.3. By End User
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Virus Testing Kits Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Test Type
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By End User
    • 7.3.2. United Kingdom Virus Testing Kits Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Test Type
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By End User
    • 7.3.3. Italy Virus Testing Kits Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecasty
        • 7.3.3.2.1. By Test Type
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By End User
    • 7.3.4. France Virus Testing Kits Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Test Type
        • 7.3.4.2.2. By Application
        • 7.3.4.2.3. By End User
    • 7.3.5. Spain Virus Testing Kits Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Test Type
        • 7.3.5.2.2. By Application
        • 7.3.5.2.3. By End User

8. Asia-Pacific Virus Testing Kits Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Test Type
    • 8.2.2. By Application
    • 8.2.3. By End User
    • 8.2.4. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Virus Testing Kits Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Test Type
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By End User
    • 8.3.2. India Virus Testing Kits Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Test Type
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By End User
    • 8.3.3. Japan Virus Testing Kits Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Test Type
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By End User
    • 8.3.4. South Korea Virus Testing Kits Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Test Type
        • 8.3.4.2.2. By Application
        • 8.3.4.2.3. By End User
    • 8.3.5. Australia Virus Testing Kits Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Test Type
        • 8.3.5.2.2. By Application
        • 8.3.5.2.3. By End User

9. South America Virus Testing Kits Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Test Type
    • 9.2.2. By Application
    • 9.2.3. By End User
    • 9.2.4. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Virus Testing Kits Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Test Type
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By End User
    • 9.3.2. Argentina Virus Testing Kits Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Test Type
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By End User
    • 9.3.3. Colombia Virus Testing Kits Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Test Type
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By End User

10. Middle East and Africa Virus Testing Kits Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Test Type
    • 10.2.2. By Application
    • 10.2.3. By End User
    • 10.2.4. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Virus Testing Kits Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Test Type
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By End User
    • 10.3.2. Saudi Arabia Virus Testing Kits Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Test Type
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By End User
    • 10.3.3. UAE Virus Testing Kits Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Test Type
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Global Virus Testing Kits Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Business Overview
  • 15.2. Service Offerings
  • 15.3. Recent Developments
  • 15.4. Key Personnel
  • 15.5. SWOT Analysis
    • 15.5.1. Qiagen
    • 15.5.2. Abbott
    • 15.5.3. Thermo Fisher Scientific
    • 15.5.4. Becton, Dickinson and Company
    • 15.5.5. BioMerieux SA
    • 15.5.6. Quidel Corporation
    • 15.5.7. .Rapikit
    • 15.5.8. Zoetis Inc
    • 15.5.9. Luminex Corporation
    • 15.5.10. F. Hoffmann-La Roche Ltd

16. Strategic Recommendations

17. About Us & Disclaimer